Floatz logo

Rhidu

Hurler-Scheie Syndrome

Genzyme, a Sanofi CompanyPhase 3Dormant
BB
64/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
49/ 100
Competitive Position
95/ 100

Competitive context

0 Active assets in the Hurler-Scheie Syndrome cohort.

Asset / SponsorPhaseRating
Aldurazyme
Genzyme, a Sanofi Company
Phase 4A
IDURONIDASE, .ALPHA.-L-(8-HISTIDINE) (HUMAN)
Genzyme, a Sanofi Company
Phase 4BB
Rgx-111
REGENXBIO Inc.
Phase 1/2CCC

Same molecule, other indications

Rhidu is also rated in:

mucopolysaccharidosis type 1Dormant
BB
Indicative ·
64 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →